DOCSLIB.ORG

Hnrnp A/B Proteins: an Encyclopedic Assessment of Their Roles in Homeostasis and Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hnrnp A/B Proteins: an Encyclopedic Assessment of Their Roles in Homeostasis and Disease biology Review hnRNP A/B Proteins: An Encyclopedic Assessment of Their Roles in Homeostasis and Disease Patricia A. Thibault 1,2 , Aravindhan Ganesan 3, Subha Kalyaanamoorthy 4, Joseph-Patrick W. E. Clarke 1,5,6 , Hannah E. Salapa 1,2 and Michael C. Levin 1,2,5,6,* 1 Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan, Saskatoon, SK S7K 0M7, Canada; [email protected] (P.A.T.); [email protected] (J.-P.W.E.C.); [email protected] (H.E.S.) 2 Department of Medicine, Neurology Division, University of Saskatchewan, Saskatoon, SK S7N 0X8, Canada 3 ArGan’s Lab, School of Pharmacy, Faculty of Science, University of Waterloo, Waterloo, ON N2L 3G1, Canada; [email protected] 4 Department of Chemistry, Faculty of Science, University of Waterloo, Waterloo, ON N2L 3G1, Canada; [email protected] 5 Department of Health Sciences, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada 6 Department of Anatomy, Physiology and Pharmacology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada * Correspondence: [email protected] Simple Summary: The hnRNP A/B family of proteins (comprised of A1, A2/B1, A3, and A0) contributes to the regulation of the majority of cellular RNAs. Here, we provide a comprehensive overview of what is known of each protein’s functions, highlighting important differences between them. While there is extensive information about A1 and A2/B1, we found that even the basic Citation: Thibault, P.A.; Ganesan, A.; functions of the A0 and A3 proteins have not been well-studied. We also noted that the regulation Kalyaanamoorthy, S.; Clarke, and tissue distribution of all four of the proteins and their different isoforms require further study. J.-P.W.E.; Salapa, H.E.; Levin, M.C. Finally, since these proteins together play such a central role in regulating the cell’s RNA, we call for hnRNP A/B Proteins: An careful comparative examination of these proteins to better define the precise boundaries of each Encyclopedic Assessment of Their Roles in Homeostasis and Disease. protein’s role in cell function and disease. Biology 2021, 10, 712. https:// doi.org/10.3390/biology10080712 Abstract: The hnRNP A/B family of proteins is canonically central to cellular RNA metabolism, but due to their highly conserved nature, the functional differences between hnRNP A1, A2/B1, A0, and Academic Editors: Stylianos A3 are often overlooked. In this review, we explore and identify the shared and disparate homeostatic Ravanidis and Epaminondas Doxakis and disease-related functions of the hnRNP A/B family proteins, highlighting areas where the proteins have not been clearly differentiated. Herein, we provide a comprehensive assembly of Received: 15 June 2021 the literature on these proteins. We find that there are critical gaps in our grasp of A/B proteins’ Accepted: 21 July 2021 alternative splice isoforms, structures, regulation, and tissue and cell-type-specific functions, and Published: 24 July 2021 propose that future mechanistic research integrating multiple A/B proteins will significantly improve our understanding of how this essential protein family contributes to cell homeostasis and disease. Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in Keywords: RNA binding protein; hnRNP A/B; RNA metabolism; splicing; RNA trafficking; RNA published maps and institutional affil- granules; RNA homeostasis; telomeres; neurodegenerative disease iations. 1. A Brief History of the hnRNPs Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. Heterogeneous nuclear ribonucleoproteins, “hnRNPs”, were first defined as proteins This article is an open access article associated with heterogeneous nuclear RNAs (hnRNAs), but not with chromatin, nucle- distributed under the terms and olar RNAs, nor polyribosomal RNAs [1,2]. These “hnRNAs” were later understood to conditions of the Creative Commons be pre-mRNAs and spliced mRNAs that had not yet left the nucleus. Early exploration Attribution (CC BY) license (https:// of hnRNPs was largely chemical and biochemical in nature, with initial studies isolating creativecommons.org/licenses/by/ purified cellular nuclei, and employing sucrose and cesium chloride gradients to isolate 4.0/). protein:RNA complexes that sedimented at approximately 40S. RNase treatments and Biology 2021, 10, 712. https://doi.org/10.3390/biology10080712 https://www.mdpi.com/journal/biology Biology 2021, 10, 712 2 of 40 cutting-edge technologies like UV-crosslinking, two-dimensional gel electrophoresis, and Edman protein sequencing were then employed to define the chemical characteristics and amino acid sequences of the proteins of interest [3–10]. Speculation about protein function was limited since individual hnRNPs’ preference for DNA or RNA binding, and any sequence specificity, was not immediately apparent [2,10–12]. Instead, in electron micrographs, hnRNPs appeared to bundle nuclear RNAs much the same way histones bundle chromosomal DNA [13]. Since these protein complexes appeared to be exclusively found in the nuclear fraction of cells [14,15], and proteins with similar molecular weights and isoelectric points (pI) were occasionally associated with chromatin, they were hypothe- sized to bundle and store newly-transcribed mRNAs until the mRNAs were needed in the cytoplasm [2,9,12]. With increasingly sophisticated biochemical tools, including the advent of monoclonal antibodies [10,16–18], hnRNPs were better defined as approximately twenty-five different nuclear proteins (hnRNP A through U) with varying affinity for hnRNAs [7,19]. Some hnRNPs were separately identified and characterized in other contexts, and are now more commonly known by other names: Auf1 (hnRNP D), PCBP1 & 2 (Poly(RC) binding proteins 1 & 2; hnRNP E1 & E2), RBMX (RNA binding motif protein, X-linked; hnRNP G), PTB-1 (Polypyrimidine tract binding protein 1; hnRNP I), FUS (fused-in-sarcoma; hnRNP P2), SYNCRIP (Synaptotagmin binding cytoplasmic RNA interacting protein; hnRNP Q). However, a core subset of six hnRNPs (hnRNP A1, A2, B1, B2, C1, and C2) were found to be highly expressed, and consistently tightly associated with hnRNAs [9,20]. Of these, hnRNP A1 and A2 were most abundant, representing approximately 60% of the hnRNP mass in HeLa cells [9]. All six species were found to have affinity for nucleic acids, from single-stranded DNA (ssDNA) to poly-adenylated RNAs and purified hnRNAs. hnRNP C proteins demonstrated the highest affinity for RNAs, and an acidic pI of 5.9 [9]. In contrast, the hnRNP A and B proteins were distinguished by their highly basic pIs ranging from 8.2 to 9.6, with the additional unusual characteristics of high glycine content and enriched asymmetrical di-methylated arginine content [7,9,10]. Thus, without knowledge of their domain architecture, enzymatic activities, or function, the hnRNP A/B protein family (herein collectively referred to as A/B proteins) was defined. This review will focus upon the hnRNP A/B protein family members, specifically A1, A2/B1, A0, and A3, outlining their cellular function and highlighting their roles in disease pathogenesis. In particular, while the hnRNP A/B proteins share significant amino acid sequence identity (Figure1) and are all involved in multiple aspects of cellular RNA metabolism, there is clear evolutionary evidence (Figure2), supported by experimental data, that each protein fills a distinct role in cellular homeostasis. For example, all four proteins share a high N-terminal amino acid identity (Figure1C), but their C-terminal domains are more divergent in amino acid sequence and protein:protein interactors, facilitating their below-described distinct roles in the cell. To our knowledge, this is the first review to comprehensively address hnRNPs A0 and A3. It should be noted that: (1) a gene and protein product named HNRNPA1L2 (A1-like 2) that shares significant protein sequence similarity to the known hnRNP A/B proteins [21] is identified in NCBI, Uniprot, and Ensembl’s databases [22–24], but lacks any functional data, and (2) the confusingly-named HNRNPAB (protein: hnRNP AB or CBF-A) and CIRBP (protein: cold-inducible RNA binding protein, hnRNP A18) are evolutionarily distinct from the hnRNP A/B family proteins [25]; thus, these proteins will not be discussed further in this review. BiologyBiology2021 2021, 10, ,10 712, x FOR PEER REVIEW 3 of3 of41 40 FigureFigure 1. 1.Human Human hnRNP hnRNP A/B A/B proteins proteins areare closelyclosely relatedrelated and share similar alternative alternative exonic exonic structures. structures. Protein Protein sequences sequences fromfrom the the full-length full-length isoform isoform for for each each hnRNP hnRNP A/B A/B proteinprotein familyfamily membermember were aligned using using ClustalW ClustalW [26] [26].. (A (A) )Percent Percent identityidentity matrix matrix for for the the full-length full-length iso isoformsforms for for each each hnRNP hnRNP A/B A/B protein protein family family member member:: A0 (NCBI A0 (NCBI Protein Protein accession accession num- ber NP_006796.1); A1-B (NP_112420.1); B1 (NP_112533.1); A3-1 (NP_001317178.1). Boxes are shaded red to indicate degree number NP_006796.1); A1-B (NP_112420.1); B1 (NP_112533.1); A3-1 (NP_001317178.1). Boxes are shaded red to indicate of sequence identity. (B) Percent identity matrix for the most common isoforms for each hnRNP A/B protein family mem- degreeber, coloured of sequence as in identity.(A). A0 (NP_006796.1); (B) Percent identity A1-A (NP_002127.1);
Load more

Recommended publications
  • The Splicing Factor U2AF1 Contributes to Cancer Progression Through a Noncanonical Role in Translation Regulation
    Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation Murali Palangat,1 Dimitrios G. Anastasakis,2 Dennis Liang Fei,3 Katherine E. Lindblad,4 Robert Bradley,5 Christopher S. Hourigan,4 Markus Hafner,2 and Daniel R. Larson1 1Laboratory of Receptor Biology and Gene Expression, National Cancer Insitute, National Institutes of Health, Bethesda, Maryland 20892, USA; 2National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA; 3Weill Cornell Medicine, New York, New York 10065, USA; 4Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA; 5Computational Biology Program, Public Health Sciences and Biological Sciences, Fred Hutchinson Cancer Center, Seattle, Washington 98109, USA Somatic mutations in the genes encoding components of the spliceosome occur frequently in human neoplasms, including myeloid dysplasias and leukemias, and less often in solid tumors. One of the affected factors, U2AF1, is involved in splice site selection, and the most common change, S34F, alters a conserved nucleic acid-binding domain, recognition of the 3′ splice site, and alternative splicing of many mRNAs. However, the role that this mutation plays in oncogenesis is still unknown. Here, we uncovered a noncanonical function of U2AF1, showing that it directly binds mature mRNA in the cytoplasm and negatively regulates mRNA translation. This splicing- independent role of U2AF1 is altered by the S34F mutation, and polysome profiling indicates that the mutation affects translation of hundreds of mRNA.
    [Show full text]
  • DNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA Stabilization
    DNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA Stabilization The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Reinhardt, H. Christian, Pia Hasskamp, Ingolf Schmedding, Sandra Morandell, Marcel A.T.M. van Vugt, XiaoZhe Wang, Rune Linding, et al. “DNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA Stabilization.” Molecular Cell 40, no. 1 (October 2010): 34–49.© 2010 Elsevier Inc. As Published http://dx.doi.org/10.1016/j.molcel.2010.09.018 Publisher Elsevier B.V. Version Final published version Citable link http://hdl.handle.net/1721.1/85107 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. Molecular Cell Article DNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA Stabilization H. Christian Reinhardt,1,6,7,8 Pia Hasskamp,1,10,11 Ingolf Schmedding,1,10,11 Sandra Morandell,1 Marcel A.T.M. van Vugt,5 XiaoZhe Wang,9 Rune Linding,4 Shao-En Ong,2 David Weaver,9 Steven A. Carr,2 and Michael B. Yaffe1,2,3,* 1David H. Koch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02132, USA 2Broad Institute of MIT and Harvard, Cambridge, MA 02132, USA 3Center for Cell Decision Processes,
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Structural and Functional Characterization of the NHR1 Domain of the Drosophila Neuralized E3 Ligase in the Notch Signaling Pathway
    doi:10.1016/j.jmb.2009.08.020 J. Mol. Biol. (2009) 393, 478–495 Available online at www.sciencedirect.com Structural and Functional Characterization of the NHR1 Domain of the Drosophila Neuralized E3 Ligase in the Notch Signaling Pathway Fahu He1, Kohei Saito1, Naohiro Kobayashi1, Takushi Harada1, Satoru Watanabe1, Takanori Kigawa1,2, Peter Güntert1,3,4, Osamu Ohara5,6, Akiko Tanaka1, Satoru Unzai7, Yutaka Muto1⁎ and Shigeyuki Yokoyama1,8⁎ 1RIKEN Systems and The Notch signaling pathway is critical for many developmental processes Structural Biology Center, and requires complex trafficking of both Notch receptor and its ligands, 1-7-22 Suehiro-cho, Tsurumi-ku, Delta and Serrate. In Drosophila melanogaster, the endocytosis of Delta in the Yokohama 230-0045, Japan signal-sending cell is essential for Notch receptor activation. The Neuralized protein from D. melanogaster (Neur) is a ubiquitin E3 ligase, which binds to 2Department of Computational Delta through its first neuralized homology repeat 1 (NHR1) domain and Intelligence and Systems mediates the ubiquitination of Delta for endocytosis. Tom, a Bearded Science, Interdisciplinary protein family member, inhibits the Neur-mediated endocytosis through Graduate School of Science interactions with the NHR1 domain. We have identified the domain and Engineering, Tokyo boundaries of the novel NHR1 domain, using a screening system based on Institute of Technology, our cell-free protein synthesis method, and demonstrated that the identified 4259 Nagatsuta-cho, Neur NHR1 domain had binding activity to the 20-residue peptide Midori-ku, Yokohama 226-8502, corresponding to motif 2 of Tom by isothermal titration calorimetry Japan experiments. We also determined the solution structure of the Neur NHR1 3Tatsuo Miyazawa Memorial domain by heteronuclear NMR methods, using a 15N/13C-labeled sample.
    [Show full text]
  • The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid
    The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome Annette K. Brenner, Elise Aasebø, Maria Hernandez-Valladares, Frode Selheim, Frode Berven, Ida-Sofie Grønningsæter, Sushma Bartaula-Brevik and Øystein Bruserud Supplementary Material S2 of S31 Table S1. Detailed information about the 68 AML patients included in the study. # of blasts Viability Proliferation Cytokine Viable cells Change in ID Gender Age Etiology FAB Cytogenetics Mutations CD34 Colonies (109/L) (%) 48 h (cpm) secretion (106) 5 weeks phenotype 1 M 42 de novo 241 M2 normal Flt3 pos 31.0 3848 low 0.24 7 yes 2 M 82 MF 12.4 M2 t(9;22) wt pos 81.6 74,686 low 1.43 969 yes 3 F 49 CML/relapse 149 M2 complex n.d. pos 26.2 3472 low 0.08 n.d. no 4 M 33 de novo 62.0 M2 normal wt pos 67.5 6206 low 0.08 6.5 no 5 M 71 relapse 91.0 M4 normal NPM1 pos 63.5 21,331 low 0.17 n.d. yes 6 M 83 de novo 109 M1 n.d. wt pos 19.1 8764 low 1.65 693 no 7 F 77 MDS 26.4 M1 normal wt pos 89.4 53,799 high 3.43 2746 no 8 M 46 de novo 26.9 M1 normal NPM1 n.d. n.d. 3472 low 1.56 n.d. no 9 M 68 MF 50.8 M4 normal D835 pos 69.4 1640 low 0.08 n.d.
    [Show full text]
  • Accepted By:- Signature Redacted Department of Biology Graduate Co-Chair: Michael T
    EXPLORING THE FUNCTIONAL CONSERVATION OF MUSCLEBLIND (MBL) PROTEINS by MASSACH USETTS INSTITUTE Julia C. Oddo d o ECHNOLOGY B.S. Molecular, Cellular, and Developmental Biology, SE 1 7 2015 Minor Biochemistry 2011 LIB RARIES SUBMITTED TO THE DEPARTMENT OF BIOLOGY IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTERS OF SCIENCE IN BIOLOGY AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY SEPTEMBER 2015 C 2015 Massachusetts Institute of Technology. All rights reserved. The author hereby grants to MIT permission to reproduce and to distribute publicly paper and electronic copies of this thesis document in whole or in part in any medium now known or hereafter created. Signature redacted Signature of Auth or:_ Department of Biology May 22, 2015 Certified by: Signature redacte Thesis Supervisor: Chris B. Burge Professor of Biology and Biological Engineering Director Program CSB Certified by: Signature redactec Thesis Co-Supervisor: Eric T. Wang Research Fellow Accepted by:- Signature redacted Department of Biology Graduate Co-Chair: Michael T. Hemann Associate Professor of Biology 1 EXPLORING THE FUNCTIONAL CONSERVATION OF MUSCLEBLIND (MBL) PROTEINS by Julia C. Oddo Submitted to the Department of Biology on September 8th, 2015 in Partial Fulfillment of the Requirements for the Degree of Master of Science in Biology ABSTRACT Muscleblind (Mbl) is an evolutionarily conserved family of proteins involved in many aspects of RNA metabolism, including alternative splicing. Disruption of Muscleblind in several animals lends to a variety of defects and disease, including the multi-systemic disorder Myotonic Dystrophy (DM). Though much is known about the involvement of Muscleblind in DM, there is much basic knowledge of the protein's function to be discovered.
    [Show full text]
  • Genes with 5' Terminal Oligopyrimidine Tracts Preferentially Escape Global Suppression of Translation by the SARS-Cov-2 NSP1 Protein
    Downloaded from rnajournal.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Genes with 5′ terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein Shilpa Raoa, Ian Hoskinsa, Tori Tonna, P. Daniela Garciaa, Hakan Ozadama, Elif Sarinay Cenika, Can Cenika,1 a Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA 1Corresponding author: [email protected] Key words: SARS-CoV-2, Nsp1, MeTAFlow, translation, ribosome profiling, RNA-Seq, 5′ TOP, Ribo-Seq, gene expression 1 Downloaded from rnajournal.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract Viruses rely on the host translation machinery to synthesize their own proteins. Consequently, they have evolved varied mechanisms to co-opt host translation for their survival. SARS-CoV-2 relies on a non-structural protein, Nsp1, for shutting down host translation. However, it is currently unknown how viral proteins and host factors critical for viral replication can escape a global shutdown of host translation. Here, using a novel FACS-based assay called MeTAFlow, we report a dose-dependent reduction in both nascent protein synthesis and mRNA abundance in cells expressing Nsp1. We perform RNA-Seq and matched ribosome profiling experiments to identify gene-specific changes both at the mRNA expression and translation level. We discover that a functionally-coherent subset of human genes are preferentially translated in the context of Nsp1 expression. These genes include the translation machinery components, RNA binding proteins, and others important for viral pathogenicity. Importantly, we uncovered a remarkable enrichment of 5′ terminal oligo-pyrimidine (TOP) tracts among preferentially translated genes.
    [Show full text]
  • The Solution Structure of Dead End Bound to AU-Rich RNA Reveals an Unprecedented Mode of Tandem RRM-RNA Recognition Required for Mrna Repression
    bioRxiv preprint doi: https://doi.org/10.1101/572156; this version posted March 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The solution structure of Dead End bound to AU-rich RNA reveals an unprecedented mode of tandem RRM-RNA recognition required for mRNA repression Authors Malgorzata M. Duszczyk1*, Harry Wischnewski2, Tamara Kazeeva1, Fionna E. Loughlin1,4, Christine von Schroetter1, Ugo Pradère3, Jonathan Hall3, Constance Ciaudo2*, Frédéric H.-T. Allain1,5* Affiliations 1Institute of Molecular Biology and Biophysics and 2Institute of Molecular Health Sciences, Department of Biology, 3Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zürich, 8093, Zürich, Switzerland 4Present Address: Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, 3800 VIC, Australia 5Lead Contact Contact Information *To whom correspondence should be addressed. E-mail: [email protected] (M.M.D.), [email protected] (C.C.), [email protected] (F.H.- T.A.) Abstract Dead End (DND1) is an RNA-binding protein essential for germline development through its role in the clearance of AU-rich mRNAs. Here, we present the solution structure of its tandem RNA Recognition Motifs (RRMs) bound to AU-rich RNA. The structure reveals how an NYAYUNN element is recognized in agreement with recent genome-wide studies. RRM1 acts as a main binding platform, including unusual helical and -hairpin extensions to the canonical RRM fold.
    [Show full text]
  • In Patients with Rheumatoid Arthritis This Information Is Current As of September 26, 2021
    Characterization of Autoreactive T Cells to the Autoantigens Heterogeneous Nuclear Ribonucleoprotein A2 (RA33) and Filaggrin in Patients with Rheumatoid Arthritis This information is current as of September 26, 2021. Ruth Fritsch, Daniela Eselböck, Karl Skriner, Beatrice Jahn-Schmid, Clemens Scheinecker, Barbara Bohle, Makiyeh Tohidast-Akrad, Silvia Hayer, Josef Neumüller, Serafin Pinol-Roma, Josef S. Smolen and Günter Steiner J Immunol 2002; 169:1068-1076; ; Downloaded from doi: 10.4049/jimmunol.169.2.1068 http://www.jimmunol.org/content/169/2/1068 References This article cites 83 articles, 9 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/169/2/1068.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 26, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Characterization of Autoreactive T Cells to the Autoantigens Heterogeneous Nuclear Ribonucleoprotein A2 (RA33) and Filaggrin in Patients with Rheumatoid Arthritis1 Ruth Fritsch,* Daniela Eselbo¨ck,* Karl Skriner,*† Beatrice Jahn-Schmid,*‡ Clemens Scheinecker,2* Barbara Bohle,‡ Makiyeh Tohidast-Akrad,¶ Silvia Hayer,* Josef Neumu¨ller,§ Serafin Pinol-Roma,ʈ Josef S.
    [Show full text]
  • Mapping of Diabetes Susceptibility Loci in a Domestic Cat Breed with an Unusually High Incidence of Diabetes Mellitus
    G C A T T A C G G C A T genes Article Mapping of Diabetes Susceptibility Loci in a Domestic Cat Breed with an Unusually High Incidence of Diabetes Mellitus 1,2, 3, 4 5 Lois Balmer y , Caroline Ann O’Leary y, Marilyn Menotti-Raymond , Victor David , Stephen O’Brien 6,7, Belinda Penglis 8, Sher Hendrickson 9, Mia Reeves-Johnson 3, 3 10 3 3,11, Susan Gottlieb , Linda Fleeman , Dianne Vankan , Jacquie Rand z and 1, , Grant Morahan * z 1 Centre for Diabetes Research, Harry Perkins Institute for Medical Research, University of Western Australia, Nedlands 6009, Australia; [email protected] 2 School of Medical and Health Sciences, Edith Cowan University, Joondalup, Perth 6027, Australia 3 School of Veterinary Science, the University of Queensland, Gottan 4343, Australia; [email protected] (C.A.O.); [email protected] (M.R.-J.); [email protected] (S.G.); [email protected] (D.V.); [email protected] (J.R.) 4 Laboratory of Genomic Diversity, Center for Cancer Research (FNLCR), Frederick, MD 21702, USA; [email protected] 5 Laboratory of Basic Research, Center for Cancer Research (FNLCR), National Cancer Institute, Frederick, MD 21702, USA; [email protected] 6 Laboratory of Genomics Diversity, Center for Computer Technologies, ITMO University, 197101 St. Petersburg, Russia; [email protected] 7 Guy Harvey Oceanographic Center, Halmos College of Arts and Sciences, Nova Southeastern University, Ft Lauderdale, FL 33004, USA 8 IDEXX Laboratories, East Brisbane 4169, Australia; [email protected] 9 Department of Biology, Shepherd University, Shepherdstown, WV 25443, USA; [email protected] 10 Animal Diabetes Australia, Melbourne 3155, Australia; l.fl[email protected] 11 American College of Veterinary Internal Medicine, University of Zurich, 8006 Zurich, Switzerland * Correspondence: [email protected] These authors contributed equally to this work.
    [Show full text]
  • Investigation of the Underlying Hub Genes and Molexular Pathogensis in Gastric Cancer by Integrated Bioinformatic Analyses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Investigation of the underlying hub genes and molexular pathogensis in gastric cancer by integrated bioinformatic analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The high mortality rate of gastric cancer (GC) is in part due to the absence of initial disclosure of its biomarkers. The recognition of important genes associated in GC is therefore recommended to advance clinical prognosis, diagnosis and and treatment outcomes. The current investigation used the microarray dataset GSE113255 RNA seq data from the Gene Expression Omnibus database to diagnose differentially expressed genes (DEGs). Pathway and gene ontology enrichment analyses were performed, and a proteinprotein interaction network, modules, target genes - miRNA regulatory network and target genes - TF regulatory network were constructed and analyzed. Finally, validation of hub genes was performed. The 1008 DEGs identified consisted of 505 up regulated genes and 503 down regulated genes.
    [Show full text]
  • RNA Dynamics in Alzheimer's Disease
    molecules Review RNA Dynamics in Alzheimer’s Disease Agnieszka Rybak-Wolf 1,* and Mireya Plass 2,3,4,* 1 Max Delbrück Center for Molecular Medicine (MDC), Berlin Institute for Medical Systems Biology (BIMSB), 10115 Berlin, Germany 2 Gene Regulation of Cell Identity, Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, 08908 Barcelona, Spain 3 Program for Advancing Clinical Translation of Regenerative Medicine of Catalonia, P-CMR[C], L’Hospitalet del Llobregat, 08908 Barcelona, Spain 4 Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28029 Madrid, Spain * Correspondence: [email protected] (A.R.-W.); [email protected] (M.P.) Abstract: Alzheimer’s disease (AD) is the most common age-related neurodegenerative disorder that heavily burdens healthcare systems worldwide. There is a significant requirement to understand the still unknown molecular mechanisms underlying AD. Current evidence shows that two of the major features of AD are transcriptome dysregulation and altered function of RNA binding proteins (RBPs), both of which lead to changes in the expression of different RNA species, including microRNAs (miRNAs), circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), and messenger RNAs (mRNAs). In this review, we will conduct a comprehensive overview of how RNA dynamics are altered in AD and how this leads to the differential expression of both short and long RNA species. We will describe how RBP expression and function are altered in AD and how this impacts the expression of different RNA species. Furthermore, we will also show how changes in the abundance Citation: Rybak-Wolf, A.; Plass, M.
    [Show full text]